Xbrane Biopharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Anette Lindqvist, was filed 21 Jan 2021.
Xbrane Biopharma AB: what insiders have been doing
This page follows insider dealings at Xbrane Biopharma AB as filed with Finansinspektionen, a company from the Health Care sector. Xbrane Biopharma AB has had no insider filing for more than a year; the last one goes back to 28 October 2025.
Since 2021, the database holds 4 purchases and 1 sale by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,976 shares@ SEK 10.200.025% mcap100.0% of flowAktieISIN SE0026598583FI:A003T195-1
- 1,500 shares@ SEK 82.54100.0% of flowAktieISIN SE0007789409FI:A001P657-1Canonical exit: 20 Apr 2021 (T+90)
- 750 shares@ SEK 76.20100.0% of flowAktieISIN SE0007789409FI:A001P598-1Canonical exit: 18 Apr 2021 (T+90)
- 2,000 shares@ SEK 78.40100.0% of flowAktieISIN SE0007789409FI:A001P565-1Canonical exit: 15 Apr 2021 (T+90)
- 1,150 shares@ SEK 81.60100.0% of flowAktieISIN SE0007789409FI:A001P393-1Canonical exit: 8 Apr 2021 (T+90)
5 of 5 declarations
About Xbrane Biopharma AB
Xbrane Biopharma AB is a biopharmaceutical company focused on the development of biosimilars. It is listed on the XSTO market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
